TABLE 1.
Incidence and prevalence of bronchiectasis
| Country | Study, year | Source | Sample size (n) | Age group | Year | Prevalence (per 100 000) | Incidence (per 100 000 person-years) |
|---|---|---|---|---|---|---|---|
| Europe | |||||||
| UK | Quint [11] 2016 | Primary care database (Clinical Practice Research Datalink database) |
5.4 million | All | 2004 | Female: 350.5 Male: 301.2 |
Female: 21.2 Male: 18.2 |
| 2013 | Female: 566.1 Male: 485.5 |
Female: 35.2 Male: 26.9 |
|||||
| Snell [22] 2019 | Primary care database (The Health Improvement Network records) |
5% of UK population (total ∼52 million) | All | 2004 | Overall: 20 | ||
| 2012 | Female: 379 Male: 281 |
Overall: 33 | |||||
| Catalonia | Monteagudo [15] 2016 | Primary care database (Information System for the Development of Research in Primary Care) |
5.8 million (80% of the total population) |
All | 2012 | Overall: 362 Female: 391 Male: 333 |
Overall: 48.1 Female: 49.3 Male: 46.9 |
| Germany | Ringshausen [16] 2015 | Federal Insurance Authority | 3 895 272 | All | 2013 | Overall: 67 Female: 68 Male: 65 |
|
| Diel [52] 2019 | Health Risk Institute research database from more than 80 German statutory health insurance companies | 3 988 648 | All | 2011 | Overall: 16.77 | ||
| 2012 | Overall: 16.05 | ||||||
| 2013 | Overall: 21.23 | ||||||
| 2013 | Overall: 20.88 | ||||||
| Ringshausen [14] 2019 | Externally validated InGef research database claims data from public health scheme | 4 million | All | 2009 | Overall: 52.5 | ||
| 2017 | Overall: 94.8 | ||||||
| Italy | Aliberti [12] 2020 | Primary care database | 1 054 376 | ≥15 years | 2005 | Overall: 62 | |
| 2015 | Overall: 163 Female: 178 Male: 147 |
Overall: 16.3 Female: 18.2 Male: 14.1 |
|||||
| Poland | Niewiadomska [31] 2016 | National Health Found and Mz/Szp-11 reports | 4 635 882 | ≥19 years | 2006 | Overall: 19.9 Female: 21.4 Male: 18.7 |
|
| 2007 | Overall: 25.1 Female: 27.3 Male:23.4 |
||||||
| 2008 | Overall: 22.2 Female: 23.0 Male: 22.3 |
||||||
| 2009 | Overall: 23.7 Female: 26.0 Male: 21.7 |
||||||
| 2010 | Overall: 21.1 Female: 22.2 Male: 20.6 |
||||||
| America | |||||||
| USA | Weycker [23] 2005 | Healthcare claims | 5.6 million | ≥18 years | 1999–2001 | Overall: 52.3 | |
| Seitz [26] 2012 | 5% sample of the Medicare outpatient claims database | >2 million | ≥65 years | 2000–2007 (total 8-year period) |
Overall: 1106 Female: 414.8 Male: 245.7 |
||
| 2000 | Female: 322 Male: 223 |
||||||
| 2007 | Female: 553 Male: 388 |
||||||
| Weycker [25] 2017 | Truven Health Analytics MarketScan Commercial Claims and Encounters and Medicare Supplemental and Coordination of Benefits databases | Prevalence: 33.2 million Incidence: 23.7 million |
≥18 years | 2013 | Overall: 138.6 Female: 179.5 Male: 95.3 |
Overall: 28.5 Female: 33.6 Male: 23.0 |
|
| Henkle [24] 2018 | 40% of Medicare enrolees with prescription drug plans | NA | ≥65 years | 2006–2014 | Overall: 701 Female: 802 Male: 617 |
||
| 2012 | Overall: 694 | ||||||
| 2013 | Overall: 694 | ||||||
| 2014 | Overall: 714 | ||||||
| Asia | |||||||
| China | Zhou [13] 2013 | Urban population–based cross sectional survey of bronchiectasis | 10 811 | ≥40 years | 2002–2004 | Overall: 1248.7 (135/10 811) Female: 1088.8 (70/6429) Male: 1483.3 (65/4382) |
|
| Feng [17] 2022 | Urban Employee Basic Medical Insurance and Urban Resident Basic Medical Insurance in China | >380 million | ≥18 years | 2013 | Overall: 75.48 Female: 76.12 Male: 73.42 |
||
| 2014 | Overall: 112.61 Female: 115.45 Male: 109.71 |
||||||
| 2015 | Overall: 120.41 Female: 119.19 Male: 122.03 |
||||||
| 2016 | Overall: 131.97 Female: 133.13 Male: 131.20 |
||||||
| 2017 | Overall: 174.45 Female: 173.60 Male: 175.03 |
||||||
| Singapore | Phua [20] 2021 | Ministry of Health-hosted administrative database | NA | All | 2007 | Overall: 13.9 | |
| 2008 | Overall: 12.5 | ||||||
| 2009 | Overall: 12.4 | ||||||
| 2010 | Overall: 11.4 | ||||||
| 2011 | Overall: 12.4 | ||||||
| 2012 | Overall: 11.0 | ||||||
| 2013 | Overall: 9.6 | ||||||
| 2014 | Overall: 9.4 | ||||||
| 2015 | Overall: 9.5 | ||||||
| 2016 | Overall: 10.6 | ||||||
| 2017 | Overall: 147.1 | Overall: 10.6 | |||||
| South Korea | Choi [18] 2019 | Health Insurance Review and Assessment Service, National Patient Sample | 1.4 million | ≥20 years | 2012–2017 | Overall: 464 | |
| 2012 | Overall: 464 | ||||||
| 2013 | Overall: 441 | ||||||
| 2014 | Overall: 455 | ||||||
| 2015 | Overall: 474 | ||||||
| 2016 | Overall: 468 | ||||||
| 2017 | Overall: 480 | ||||||
| Park [21] 2021 | National Health Insurance Service–National Sample Cohort data | 1 025 340 | All | 2007 | Female: 154.3 Male: 120.9 |
||
| 2009 | Female: 183 Male: 174.5 |
||||||
| 2015 | Female: 343.1 Male: 266.4 |
Female: 150.3 Male: 126.6 |
|||||
Studies are grouped according to the geographical area in which they have been conducted (i.e. continents and countries). NA: not available/applicable.